Decline in pharmacy revenue stream explained pretty well.
Don't underestimate the continued effect of PBS (price disclosure) generic price reductions. Also the program of Hepatitis C vaccination of up to 60,000 plus patients has tapered off. Each 12 week course costs over $100k. So in prior years it artificially boosted all wholesalers revenue figures. The margin for distribution was peanuts so the loss of this revenue is insignificant in terms of the bottom line.
Decline in pharmacy revenue stream explained pretty well. Don't...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SIG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.85 |
Change
-0.060(2.06%) |
Mkt cap ! $2.300B | |||
| Open | High | Low | Value | Volume |
| $2.91 | $2.92 | $2.85 | $5.257M | 1.817M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 37 | 116213 | $2.85 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.86 | 85769 | 33 |
View Market Depth
| Last trade - 12.39pm 04/12/2024 (20 minute delay) ? |
| SIG (ASX) Chart |
